Publications by authors named "Damian Stephan"

Claim this Profile
I
Importance of the Kir6.2 N-terminus for the interaction of glibenclamide and repaglinide with the pancreatic K(ATP) channel.
Petra Kühner, Renate Prager, Damian Stephan, Ulrich Russ, Marcus Winkler

Naunyn Schmiedebergs Arch Pharmacol· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Testing the bipartite model of the sulfonylurea receptor binding site: binding of A-, B-, and A + B-site ligands.
Marcus Winkler, Damian Stephan, Susanne Bieger, Petra Kühner, Felix Wolff

J Pharmacol Exp Ther· August 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lipids modulate ligand binding to sulphonylurea receptors.
Alexander Klein, Jochen Lichtenberg, Damian Stephan, Ulrich Quast

Br J Pharmacol· August 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The mutation Y1206S increases the affinity of the sulphonylurea receptor SUR2A for glibenclamide and enhances the effects of coexpression with Kir6.2.
Damian Stephan, Eva Stauss, Ulf Lange, Holger Felsch, Cornelia Löffler-Walz

Br J Pharmacol· April 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of ATP-sensitive K+ channel subtype selectivity of insulin secretagogues for the coronary vasculature and the myocardium.
Ulrich Quast, Damian Stephan, Susanne Bieger, Ulrich Russ

Diabetes· December 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis